Dudediligence.

Phathom Pharmaceuticals, Inc

PHATNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$16.4MSep ’24$29.7MDec ’24$28.5MMar ’25$39.5MJun ’25$49.5MSep ’25$57.6MDec ’25$58.3MMar ’26$74.3MJun ’26
Net income, by quarter
−$85.6MSep ’24−$74.5MDec ’24−$94.3MMar ’25−$75.8MJun ’25−$30.0MSep ’25$199.9MDec ’25−$30.4MMar ’26−$17.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$0.00$682,000$55.3M$175.1M
Gross profitnone on file$0.00$515,000$47.3M$152.5M
Operating income−$135.1M−$172.4M−$167.3M−$277.5M−$160.0M
Net income−$143.9M−$197.7M−$201.6M−$334.3M−$221,250
Operating cash flow−$148.5M−$146.5M−$137.6M−$266.8M−$166.8M
Free cash flow−$148.8M−$147.6M−$139.2M−$266.9M−$167.0M
Cash$183.3M$155.4M$381.4M$297.3M$130.0M
Debt$89.7M$95.3M$137.8M$201.4M$209.1M
Shares outstanding30.5M41.5M58.0M68.5M71.4M